(Q31122463)

29 June 2017

title

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board (English)

1 reference

29 June 2017

0 references

Elizabeth Barrett-Connor

2

object named as

Elizabeth Barrett-Connor

0 references

Eugene Braunwald

3

object named as

Eugene Braunwald

1 reference

29 June 2017

8

Johanna Dwyer

1 reference

29 June 2017

1

Janet Wittes

1 reference

29 June 2017

12

Salim Yusuf

1 reference

29 June 2017

4

Margaret Chesney

1 reference

29 June 2017

9

Robert P Heaney

1 reference

29 June 2017

Harvey Jay Cohen

5

1 reference

29 June 2017

David Demets

6

1 reference

29 June 2017

Leo Dunn

7

1 reference

29 June 2017

Victor Vogel

10

1 reference

29 June 2017

Leroy Walters

11

1 reference

29 June 2017

publication date

1 January 2007

1 reference

29 June 2017

1 reference

29 June 2017

volume

4

1 reference

29 June 2017

issue

3

1 reference

29 June 2017

page(s)

218-234

1 reference

Design of the Women’s Health Initiative Clinical Trial and Observational Study

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Calcium plus vitamin D supplementation and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Approached to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Variable impact of combining fatal and nonfatal end points in heart failure trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

The Coronary Drug Project. Monitoring of the data for evidence of adverse or beneficial treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Oral contraceptives and cardiovascular disease (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Oral contraceptives and cardiovascular disease (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

A clinical trial of estrogen-replacement therapy after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

The agonising negative trend in monitoring of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774507079439

21 January 2018

Identifiers

DOI

10.1177/1740774507079439

1 reference

29 June 2017

1 reference